Logo image of GBLB.BR

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Stock Fundamental Analysis

Europe - EBR:GBLB - BE0003797140 - Common Stock

73.85 EUR
-0.55 (-0.74%)
Last: 11/17/2025, 5:36:15 PM
Fundamental Rating

3

Taking everything into account, GBLB scores 3 out of 10 in our fundamental rating. GBLB was compared to 52 industry peers in the Financial Services industry. GBLB has an average financial health and profitability rating. GBLB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year GBLB was profitable.
In the past year GBLB had a positive cash flow from operations.
Of the past 5 years GBLB 4 years were profitable.
In the past 5 years GBLB always reported a positive cash flow from operatings.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

The Return On Assets of GBLB (0.52%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 1.07%, GBLB is in line with its industry, outperforming 44.23% of the companies in the same industry.
GBLB has a Return On Invested Capital of 0.96%. This is in the lower half of the industry: GBLB underperforms 61.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GBLB is significantly below the industry average of 9.75%.
The last Return On Invested Capital (0.96%) for GBLB is above the 3 year average (0.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.52%
ROE 1.07%
ROIC 0.96%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 1.98%, GBLB is in line with its industry, outperforming 44.23% of the companies in the same industry.
In the last couple of years the Profit Margin of GBLB has declined.
GBLB's Operating Margin of 5.49% is in line compared to the rest of the industry. GBLB outperforms 42.31% of its industry peers.
GBLB's Operating Margin has declined in the last couple of years.
GBLB's Gross Margin of 62.71% is fine compared to the rest of the industry. GBLB outperforms 65.38% of its industry peers.
In the last couple of years the Gross Margin of GBLB has remained more or less at the same level.
Industry RankSector Rank
OM 5.49%
PM (TTM) 1.98%
GM 62.71%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBLB is destroying value.
GBLB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for GBLB has been reduced compared to 5 years ago.
The debt/assets ratio for GBLB is higher compared to a year ago.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that GBLB is in the distress zone and has some risk of bankruptcy.
GBLB's Altman-Z score of 1.31 is in line compared to the rest of the industry. GBLB outperforms 44.23% of its industry peers.
The Debt to FCF ratio of GBLB is 12.98, which is on the high side as it means it would take GBLB, 12.98 years of fcf income to pay off all of its debts.
GBLB has a Debt to FCF ratio (12.98) which is in line with its industry peers.
A Debt/Equity ratio of 0.51 indicates that GBLB is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.51, GBLB is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 12.98
Altman-Z 1.31
ROIC/WACC0.16
WACC6.02%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.91 indicates that GBLB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.91, GBLB is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
A Quick Ratio of 1.56 indicates that GBLB should not have too much problems paying its short term obligations.
GBLB has a Quick ratio of 1.56. This is in the better half of the industry: GBLB outperforms 67.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.56
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

GBLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.95%.
The earnings per share for GBLB have been decreasing by -26.51% on average. This is quite bad
The Revenue has decreased by -1.53% in the past year.
Measured over the past years, GBLB shows a small growth in Revenue. The Revenue has been growing by 3.51% on average per year.
EPS 1Y (TTM)-91.95%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-23.15%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%1.86%

3.2 Future

The Earnings Per Share is expected to decrease by -6.19% on average over the next years.
Based on estimates for the next years, GBLB will show a small growth in Revenue. The Revenue will grow by 2.33% on average per year.
EPS Next Y-28.35%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
EPS Next 5YN/A
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 76.93, which means the current valuation is very expensive for GBLB.
61.54% of the companies in the same industry are cheaper than GBLB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of GBLB to the average of the S&P500 Index (25.56), we can say GBLB is valued expensively.
With a Price/Forward Earnings ratio of 21.14, GBLB is valued on the expensive side.
GBLB's Price/Forward Earnings is on the same level as the industry average.
GBLB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 76.93
Fwd PE 21.14
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBLB is valued a bit cheaper than 65.38% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as GBLB.
Industry RankSector Rank
P/FCF 16.7
EV/EBITDA 12.97
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

GBLB's earnings are expected to decrease with -6.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.69%, GBLB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.37, GBLB pays a better dividend. On top of this GBLB pays more dividend than 84.62% of the companies listed in the same industry.
GBLB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 4.69%

5.2 History

The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years1
Div Non Decr Years4
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

GBLB pays out 468.18% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of GBLB has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP468.18%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
GBLB.BR Dividend Payout.GBLB.BR Dividend Payout, showing the Payout Ratio.GBLB.BR Dividend Payout.PayoutRetained Earnings

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (11/17/2025, 5:36:15 PM)

73.85

-0.55 (-0.74%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-12 2026-03-12
Inst Owners25.81%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap9.84B
Revenue(TTM)6.68B
Net Income(TTM)132.30M
Analysts83.08
Price Target87.84 (18.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.69%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP468.18%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.76%
PT rev (3m)1.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 76.93
Fwd PE 21.14
P/S 1.47
P/FCF 16.7
P/OCF 8.16
P/B 0.8
P/tB 1.87
EV/EBITDA 12.97
EPS(TTM)0.96
EY1.3%
EPS(NY)3.49
Fwd EY4.73%
FCF(TTM)4.42
FCFY5.99%
OCF(TTM)9.05
OCFY12.25%
SpS50.19
BVpS92.77
TBVpS39.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.76
Profitability
Industry RankSector Rank
ROA 0.52%
ROE 1.07%
ROCE 1.63%
ROIC 0.96%
ROICexc 1.13%
ROICexgc 1.79%
OM 5.49%
PM (TTM) 1.98%
GM 62.71%
FCFM 8.81%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
ROICexc(3y)0.92%
ROICexc(5y)1.25%
ROICexgc(3y)1.32%
ROICexgc(5y)1.66%
ROCE(3y)1.37%
ROCE(5y)1.91%
ROICexgc growth 3Y-6.63%
ROICexgc growth 5Y-8.4%
ROICexc growth 3Y-11.16%
ROICexc growth 5Y-11.6%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 12.98
Debt/EBITDA 6.63
Cap/Depr 104.99%
Cap/Sales 9.21%
Interest Coverage 0.96
Cash Conversion 126.32%
Profit Quality 445.28%
Current Ratio 1.91
Quick Ratio 1.56
Altman-Z 1.31
F-Score5
WACC6.02%
ROIC/WACC0.16
Cap/Depr(3y)97.68%
Cap/Depr(5y)87.97%
Cap/Sales(3y)10%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.95%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-23.15%
EPS Next Y-28.35%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%1.86%
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A
EBIT growth 1Y-41.9%
EBIT growth 3Y-19.25%
EBIT growth 5Y-15.81%
EBIT Next Year9.24%
EBIT Next 3Y5.06%
EBIT Next 5YN/A
FCF growth 1Y82.78%
FCF growth 3Y8.34%
FCF growth 5Y2.47%
OCF growth 1Y13.85%
OCF growth 3Y8.48%
OCF growth 5Y4.55%

GROUPE BRUXELLES LAMBERT NV / GBLB.BR FAQ

What is the ChartMill fundamental rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GBLB.BR.


What is the valuation status of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to GROUPE BRUXELLES LAMBERT NV (GBLB.BR). This can be considered as Overvalued.


What is the profitability of GBLB stock?

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) has a profitability rating of 4 / 10.


What are the PE and PB ratios of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

The Price/Earnings (PE) ratio for GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 76.93 and the Price/Book (PB) ratio is 0.8.


How financially healthy is GROUPE BRUXELLES LAMBERT NV?

The financial health rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 4 / 10.